Molecular mechanisms of cholecystokinin-B/gastrin receptor activation - Implications for non-peptide drug discovery.

被引：0
|
作者：
Beinborn, M
Kopin, AS
机构：
[1] Tufts Univ, New England Med Ctr, Dept Med, Boston, MA 02111 USA
[2] Tufts Univ, New England Med Ctr, GRASP Digest Dis Res Ctr, Boston, MA 02111 USA
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
12
引用
收藏
页码：R767 / R767
页数：1
相关论文
共 30 条
  • [21] Point mutations in the putative ligand binding 'pocket' of the CCK-B/gastrin receptor interconvert the functional activity of non-peptide agonists and antagonists
    Blaker, M
    Gordon, MC
    Hsu, JE
    Beinborn, M
    Kopin, AS
    GASTROENTEROLOGY, 1997, 112 (04) : A1133 - A1133
  • [22] Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists
    Meini, S
    Cucchi, P
    Bellucci, F
    Catalani, C
    Faiella, A
    Rotondaro, L
    Quartara, L
    Giolitti, A
    Maggi, CA
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (04) : 601 - 609
  • [23] Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery
    Zafar, Atif
    Ahmad, Sabahuddin
    Rizvi, Asim
    Ahmad, Masood
    PLOS ONE, 2015, 10 (05):
  • [24] Mutational analysis suggests different molecular mechanisms of CCK-B/gastrin receptor activation by endogenous peptides versus synthetic drugs.
    Bläker, M
    Ren, Y
    Sundararajan, L
    McBride, EW
    Beinborn, M
    Kopin, AS
    GASTROENTEROLOGY, 1998, 114 (04) : A1130 - A1130
  • [25] A novel class of orally active non-peptide bradykinin B2 receptor antagonists.: 4.: Discovery of novel frameworks mimicking the active conformation
    Abe, Y
    Kayakiri, H
    Satoh, S
    Inoue, T
    Sawada, Y
    Inamura, N
    Asano, M
    Aramori, I
    Hatori, C
    Sawai, H
    Oku, T
    Tanaka, H
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) : 4587 - 4598
  • [26] The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives
    Agelis, George
    Resvani, Amalia
    Durdagi, Serdar
    Spyridaki, Katerina
    Tumova, Tereza
    Slaninova, Jitina
    Giannopoulos, Panagiotis
    Vlahakos, Demetrios
    Liapakis, George
    Mavromoustakos, Thomas
    Matsoukas, John
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 358 - 374
  • [27] The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor - Evidence for a crucial role of Met-121 in the activation process
    Escrieut, C
    Gigoux, V
    Archer, E
    Verrier, S
    Maigret, B
    Behrendt, R
    Moroder, L
    Bignon, E
    Silvente-Poirot, S
    Pradayrol, L
    Fourmy, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7546 - 7555
  • [28] Discovery of the first non-peptide full agonists for the human bradykinin B2 receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks
    Sawada, Y
    Kayakiri, H
    Abe, Y
    Mizutani, T
    Inamura, N
    Asano, M
    Hatori, C
    Aramori, I
    Oku, T
    Tanaka, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (11) : 2853 - 2863
  • [29] The first selective non-peptide angiotensin AT2-receptor agonist Compound 21 attenuates TNFα-induced IL-6 expression through inhibition of NF-κB activity and activation of phosphatases
    Rompe, F.
    Hallberg, A.
    Altermann, M.
    Artuc, M.
    Bader, M.
    Schwaninger, M.
    Unger, Th
    Steckelings, U. M.
    HYPERTENSION, 2008, 52 (04) : 772 - 772
  • [30] Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Integrated Drug-Design and Structure-Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug
    Hayashi, Shigeo
    Hirao, Akiko
    Nakamura, Hiroshi
    Yamamura, Kenzo
    Mizuno, Kunihiko
    Yamashita, Hiroyo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 74 (04) : 369 - 381
123